Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future
Georgetown Scientific Research Journal October 10, 2023 Anna Douglas, Daniel Staas, Anna Hampton et al. 1 citation
Depression remains one the most commonly diagnosed mental health disorders in the United States. The Food and Drug Administration granted psilocybin breakthrough therapy status four years ago as a possible solution to this pervasive disorder. Since then, psilocybin, and hallucinogens in general, have produced promising results as alternatives to classical antidepressants. As more research...